Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy

Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superior...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS applied materials & interfaces 2022-02, Vol.14 (4), p.4914-4920
Hauptverfasser: Song, Yan, Sun, Yuan, Tang, Minglu, Yue, Zhengya, Ni, Jiatong, Zhao, Junge, Wang, Wenxin, Sun, Tiedong, Shi, Lianxu, Wang, Lei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4920
container_issue 4
container_start_page 4914
container_title ACS applied materials & interfaces
container_volume 14
creator Song, Yan
Sun, Yuan
Tang, Minglu
Yue, Zhengya
Ni, Jiatong
Zhao, Junge
Wang, Wenxin
Sun, Tiedong
Shi, Lianxu
Wang, Lei
description Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.
doi_str_mv 10.1021/acsami.1c19985
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2622278957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622278957</sourcerecordid><originalsourceid>FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</originalsourceid><addsrcrecordid>eNp1kM9PwjAUxxujEUSvHk2PxmTQdi1bj4aAkGA0Bi9elq57C8NtHe1Q519vDcjNvMP7kc_75r0vQteUDClhdKS0U1UxpJpKGYsT1KeS8yBmgp0ea8576MK5DSHjkBFxjnqhID4i2UfbZ1N25stU0KpStYAfTVbkBWQ47fAbmLLws0VVZOrblIBnVlXwaew7zo3F7RpwMw9ewDWmdsUH4GkJurUm62p_lR5N1lD9NXi1Bqua7hKd5ap0cHXIA_Q6m64m82D59LCY3C8DFYakDSKhgaeEaJ5yCpJkAD5xHYeZyAVnWkaMSyUjKtNIKUFFRHIItVZjkeZjFQ7Q7V63sWa7A9cmVeE0lKWqwexcwsaMsSiWIvLocI9qa5yzkCeNLSplu4SS5NfmZG9zcrDZL9wctHdpBdkR__PVA3d7wC8mG7OztX_1P7UfobKKLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622278957</pqid></control><display><type>article</type><title>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Song, Yan ; Sun, Yuan ; Tang, Minglu ; Yue, Zhengya ; Ni, Jiatong ; Zhao, Junge ; Wang, Wenxin ; Sun, Tiedong ; Shi, Lianxu ; Wang, Lei</creator><creatorcontrib>Song, Yan ; Sun, Yuan ; Tang, Minglu ; Yue, Zhengya ; Ni, Jiatong ; Zhao, Junge ; Wang, Wenxin ; Sun, Tiedong ; Shi, Lianxu ; Wang, Lei</creatorcontrib><description>Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.</description><identifier>ISSN: 1944-8244</identifier><identifier>EISSN: 1944-8252</identifier><identifier>DOI: 10.1021/acsami.1c19985</identifier><identifier>PMID: 35050579</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Anions - chemistry ; Anions - pharmacology ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biocompatible Materials - chemical synthesis ; Biocompatible Materials - chemistry ; Biocompatible Materials - pharmacology ; Biological and Medical Applications of Materials and Interfaces ; Cell Proliferation - drug effects ; Combined Modality Therapy ; Drug Screening Assays, Antitumor ; Female ; HeLa Cells ; Humans ; Hydrogen-Ion Concentration ; Imidazoles - chemistry ; Imidazoles - pharmacology ; Materials Testing ; Mice ; Mice, Inbred BALB C ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - pathology ; Particle Size ; Polyelectrolytes - chemistry ; Polyelectrolytes - pharmacology ; Reactive Oxygen Species - metabolism ; Surface Properties ; Tumor Microenvironment - drug effects ; Zeolites - chemistry ; Zeolites - pharmacology</subject><ispartof>ACS applied materials &amp; interfaces, 2022-02, Vol.14 (4), p.4914-4920</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</citedby><cites>FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</cites><orcidid>0000-0002-9522-3623 ; 0000-0002-7004-9235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsami.1c19985$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsami.1c19985$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35050579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Yan</creatorcontrib><creatorcontrib>Sun, Yuan</creatorcontrib><creatorcontrib>Tang, Minglu</creatorcontrib><creatorcontrib>Yue, Zhengya</creatorcontrib><creatorcontrib>Ni, Jiatong</creatorcontrib><creatorcontrib>Zhao, Junge</creatorcontrib><creatorcontrib>Wang, Wenxin</creatorcontrib><creatorcontrib>Sun, Tiedong</creatorcontrib><creatorcontrib>Shi, Lianxu</creatorcontrib><creatorcontrib>Wang, Lei</creatorcontrib><title>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</title><title>ACS applied materials &amp; interfaces</title><addtitle>ACS Appl. Mater. Interfaces</addtitle><description>Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.</description><subject>Animals</subject><subject>Anions - chemistry</subject><subject>Anions - pharmacology</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biocompatible Materials - chemical synthesis</subject><subject>Biocompatible Materials - chemistry</subject><subject>Biocompatible Materials - pharmacology</subject><subject>Biological and Medical Applications of Materials and Interfaces</subject><subject>Cell Proliferation - drug effects</subject><subject>Combined Modality Therapy</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Female</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Imidazoles - chemistry</subject><subject>Imidazoles - pharmacology</subject><subject>Materials Testing</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Particle Size</subject><subject>Polyelectrolytes - chemistry</subject><subject>Polyelectrolytes - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Surface Properties</subject><subject>Tumor Microenvironment - drug effects</subject><subject>Zeolites - chemistry</subject><subject>Zeolites - pharmacology</subject><issn>1944-8244</issn><issn>1944-8252</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9PwjAUxxujEUSvHk2PxmTQdi1bj4aAkGA0Bi9elq57C8NtHe1Q519vDcjNvMP7kc_75r0vQteUDClhdKS0U1UxpJpKGYsT1KeS8yBmgp0ea8576MK5DSHjkBFxjnqhID4i2UfbZ1N25stU0KpStYAfTVbkBWQ47fAbmLLws0VVZOrblIBnVlXwaew7zo3F7RpwMw9ewDWmdsUH4GkJurUm62p_lR5N1lD9NXi1Bqua7hKd5ap0cHXIA_Q6m64m82D59LCY3C8DFYakDSKhgaeEaJ5yCpJkAD5xHYeZyAVnWkaMSyUjKtNIKUFFRHIItVZjkeZjFQ7Q7V63sWa7A9cmVeE0lKWqwexcwsaMsSiWIvLocI9qa5yzkCeNLSplu4SS5NfmZG9zcrDZL9wctHdpBdkR__PVA3d7wC8mG7OztX_1P7UfobKKLg</recordid><startdate>20220202</startdate><enddate>20220202</enddate><creator>Song, Yan</creator><creator>Sun, Yuan</creator><creator>Tang, Minglu</creator><creator>Yue, Zhengya</creator><creator>Ni, Jiatong</creator><creator>Zhao, Junge</creator><creator>Wang, Wenxin</creator><creator>Sun, Tiedong</creator><creator>Shi, Lianxu</creator><creator>Wang, Lei</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9522-3623</orcidid><orcidid>https://orcid.org/0000-0002-7004-9235</orcidid></search><sort><creationdate>20220202</creationdate><title>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</title><author>Song, Yan ; Sun, Yuan ; Tang, Minglu ; Yue, Zhengya ; Ni, Jiatong ; Zhao, Junge ; Wang, Wenxin ; Sun, Tiedong ; Shi, Lianxu ; Wang, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Anions - chemistry</topic><topic>Anions - pharmacology</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biocompatible Materials - chemical synthesis</topic><topic>Biocompatible Materials - chemistry</topic><topic>Biocompatible Materials - pharmacology</topic><topic>Biological and Medical Applications of Materials and Interfaces</topic><topic>Cell Proliferation - drug effects</topic><topic>Combined Modality Therapy</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Female</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Imidazoles - chemistry</topic><topic>Imidazoles - pharmacology</topic><topic>Materials Testing</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Particle Size</topic><topic>Polyelectrolytes - chemistry</topic><topic>Polyelectrolytes - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Surface Properties</topic><topic>Tumor Microenvironment - drug effects</topic><topic>Zeolites - chemistry</topic><topic>Zeolites - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Yan</creatorcontrib><creatorcontrib>Sun, Yuan</creatorcontrib><creatorcontrib>Tang, Minglu</creatorcontrib><creatorcontrib>Yue, Zhengya</creatorcontrib><creatorcontrib>Ni, Jiatong</creatorcontrib><creatorcontrib>Zhao, Junge</creatorcontrib><creatorcontrib>Wang, Wenxin</creatorcontrib><creatorcontrib>Sun, Tiedong</creatorcontrib><creatorcontrib>Shi, Lianxu</creatorcontrib><creatorcontrib>Wang, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS applied materials &amp; interfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Yan</au><au>Sun, Yuan</au><au>Tang, Minglu</au><au>Yue, Zhengya</au><au>Ni, Jiatong</au><au>Zhao, Junge</au><au>Wang, Wenxin</au><au>Sun, Tiedong</au><au>Shi, Lianxu</au><au>Wang, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</atitle><jtitle>ACS applied materials &amp; interfaces</jtitle><addtitle>ACS Appl. Mater. Interfaces</addtitle><date>2022-02-02</date><risdate>2022</risdate><volume>14</volume><issue>4</issue><spage>4914</spage><epage>4920</epage><pages>4914-4920</pages><issn>1944-8244</issn><eissn>1944-8252</eissn><abstract>Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>35050579</pmid><doi>10.1021/acsami.1c19985</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-9522-3623</orcidid><orcidid>https://orcid.org/0000-0002-7004-9235</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1944-8244
ispartof ACS applied materials & interfaces, 2022-02, Vol.14 (4), p.4914-4920
issn 1944-8244
1944-8252
language eng
recordid cdi_proquest_miscellaneous_2622278957
source MEDLINE; American Chemical Society Journals
subjects Animals
Anions - chemistry
Anions - pharmacology
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Biocompatible Materials - chemical synthesis
Biocompatible Materials - chemistry
Biocompatible Materials - pharmacology
Biological and Medical Applications of Materials and Interfaces
Cell Proliferation - drug effects
Combined Modality Therapy
Drug Screening Assays, Antitumor
Female
HeLa Cells
Humans
Hydrogen-Ion Concentration
Imidazoles - chemistry
Imidazoles - pharmacology
Materials Testing
Mice
Mice, Inbred BALB C
Neoplasms, Experimental - drug therapy
Neoplasms, Experimental - metabolism
Neoplasms, Experimental - pathology
Particle Size
Polyelectrolytes - chemistry
Polyelectrolytes - pharmacology
Reactive Oxygen Species - metabolism
Surface Properties
Tumor Microenvironment - drug effects
Zeolites - chemistry
Zeolites - pharmacology
title Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A44%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polyoxometalate%20Modified%20by%20Zeolite%20Imidazole%20Framework%20for%20the%20pH-Responsive%20Electrodynamic/Chemodynamic%20Therapy&rft.jtitle=ACS%20applied%20materials%20&%20interfaces&rft.au=Song,%20Yan&rft.date=2022-02-02&rft.volume=14&rft.issue=4&rft.spage=4914&rft.epage=4920&rft.pages=4914-4920&rft.issn=1944-8244&rft.eissn=1944-8252&rft_id=info:doi/10.1021/acsami.1c19985&rft_dat=%3Cproquest_cross%3E2622278957%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622278957&rft_id=info:pmid/35050579&rfr_iscdi=true